The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Nonparametric Statistics for the Behavioral Sciences
Guitton, H., & Siegel, S. (1958) · Revue économique · doi:10.2307/3498751 · Cited by 35,245
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1977) · British Journal of Cancer · doi:10.1038/bjc.1977.1 · Cited by 8,285
Evaluation of survival data and two new rank order statistics arising in its consideration.
Mantel, N. (1966) · PubMed · Cited by 7,519
Nonparametric statistics for the behavioral sciences
McGinn, L. C. (1957) · Journal of the Franklin Institute · doi:10.1016/0016-0032(57)90766-4 · Cited by 7,204
Proportional hazards tests and diagnostics based on weighted residuals
GRAMBSCH, P. M., & THERNEAU, T. M. (1994) · Biometrika · doi:10.1093/biomet/81.3.515 · Cited by 5,885 · cited 1×
“Previous surgical resection, n (%) 25 (22) CDAI 37 (19–61) reatment history Antimetabolite treatment Methotrexate, n (%) 19 (17) Azathioprine/6-mercaptopurine, n (%) 96 (83) Antimetabolite naïvea at infliximab initiation, n (%) 51 (44)”
BackgroundMaintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Hanauer, S. B., Feagan, B. G., Lichtenstein, G. R., Mayer, L. F., Schreiber, S., Colombel, J. F., Rachmilewitz, D., Wolf, D. C., Olson, A., Bao, W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08512-4 · Cited by 4,169
Self-citationNonparametric Statistics : for the Behavioral Sciences
Siegel, S. (1956) · UCLA - Biblioteca de Ciencias y Tecnologia Felix Morales Bueno · Cited by 3,287
Development of a Crohn's Disease Activity Index
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80163-1 · Cited by 3,152
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · PubMed · Cited by 3,147
Colombel, J., Sandborn, W. J., Rutgeerts, P., Enns, R., Hanauer, S. B., Panaccione, R., Schreiber, S., Byczkowski, D., Li, J., Kent, J. D., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.041 · Cited by 2,245
Self-citationSample-Size Formula for the Proportional-Hazards Regression Model
Schoenfeld, D. A. (1983) · Biometrics · doi:10.2307/2531021 · Cited by 1,096
Maintenance Therapy with Certolizumab Pegol for Crohn's Disease
Schreiber, S., Khaliq-Kareemi, M., Lawrance, I. C., Thomsen, O. Ø., Hanauer, S. B., McColm, J., Bloomfield, R., & Sandborn, W. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062897 · Cited by 1,043
Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease
Toruner, M., Loftus, E. V., Harmsen, W. S., Zinsmeister, A. R., Orenstein, R., Sandborn, W. J., Colombel, J., & Egan, L. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.012 · Cited by 1,017
Self-citationImputing missing covariate values for the Cox model
White, I. R., & Royston, P. (2009) · Statistics in Medicine · doi:10.1002/sim.3618 · Cited by 985
Mary, J. Y., & Modigliani, R. (1989) · Gut · doi:10.1136/gut.30.7.983 · Cited by 884
Self-citationConcordance probability and discriminatory power in proportional hazards regression
Gönen, M., & Heller, G. (2005) · Biometrika · doi:10.1093/biomet/92.4.965 · Cited by 673
Loss of Response and Requirement of Infliximab Dose Intensification in Crohn's Disease: A Review
Gisbert, J. P., & Panés, J. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.88 · Cited by 664
Maser, E. A., Villela, R., Silverberg, M. S., & Greenberg, G. R. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.06.025 · Cited by 613
Farrell, R. J., Alsahli, M., Jeen, Y.-T., Falchuk, K. R., Peppercorn, M. A., & Michetti, P. (2003) · Gastroenterology · doi:10.1053/gast.2003.50145 · Cited by 550
Siegel, C. A., Marden, S. M., Persing, S. M., Larson, R. J., & Sands, B. E. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.01.004 · Cited by 511
Van Assche, G., Magdelaine–Beuzelin, C., D'Haens, G., Baert, F., Noman, M., Vermeire, S., Ternant, D., Watier, H., Paintaud, G., & Rutgeerts, P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.004 · Cited by 495
Self-citationKane, S. V., & Acquah, L. A. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.71 · Cited by 267
Cancer Clinical Trials: Methods and Practice.
Freedman, L. S., Buyse, M. E., Staquet, M., et al. (1985) · Biometrics · doi:10.2307/2531305 · Cited by 209
Bodger, K., KIKUCHI, T., & Hughes, D. A. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04033.x · Cited by 124
Chong, S. F., & Choo, R. W. M. (2011) · Proceedings of Singapore Healthcare · doi:10.1177/201010581102000314 · Cited by 107
An Enzyme-Linked Immunosorbent Assay for Therapeutic Drug Monitoring of Infliximab
Ternant, D., Mulleman, D., Degenne, D., et al. (2006) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000189901.08684.4b · Cited by 104
An enzyme-linked immunosorbent assay for therapeutic drug monitoring of Cetuximab
Ternant, D., Cézé, N., Piller, F., Degenne, D., Dorval, E., Watier, H., Lecomte, T., & Paintaud, G. (2009) · HAL · Cited by 100
Self-citationBaraliakos, X., Listing, J., Rudwaleit, M., Brandt, J., Alten, R., Burmester, G. R., Gromnica‐Ihle, E., Haibel, H., Schewe, S., Schneider, M., et al. (2007) · PubMed · Cited by 67
Cancer Clinical Trials: Methods and Practice.
Ryzin, J. V., Buyse, M. E., Staquet, M. J., et al. (1986) · Journal of the American Statistical Association · doi:10.2307/2289265 · Cited by 58
Economic Implications of Biological Therapies for Crohn???s Disease: Review of Infliximab
Bodger, K. (2005) · PharmacoEconomics · doi:10.2165/00019053-200523090-00002 · Cited by 28
Domènech, E., Zabana, Y., Mañosa, M., García-Planella, E., Cabré, E., & Gassull, M. A. (2009) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181962dfa · Cited by 27
Cited by
Torres, J., Mehandru, S., Colombel, J.-F., & Peyrin-Biroulet, L. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31711-1 · Cited by 2,682
Self-citationLamb, C. A., Kennedy, N. A., Raine, T., Hendy, P. A., Smith, P. J., Limdi, J. K., Hayee, B., Lomer, M. C. E., Parkes, G. C., Selinger, C., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318484 · Cited by 2,346
Baumgart, D. C., & Sandborn, W. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60026-9 · Cited by 2,154
Peyrin-Biroulet, L., Sandborn, W., Sands, B. E., Reinisch, W., Bemelman, W., Bryant, R. V., D'Haens, G., Dotan, I., Dubinsky, M., Feagan, B., et al. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.233 · Cited by 1,844
Self-citationMaaser, C., Sturm, A., Vavricka, S. R., Kucharzik, T., Fiorino, G., Annese, V., Calabrese, E., Baumgart, D. C., Bettenworth, D., Borralho Nunes, P., et al. (2019) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjy113 · Cited by 1,823
Metadata
- Authors
- Louis, E., Mary, J., Vernier–Massouille, G., Grimaud, J., Bouhnik, Y., Laharie, D., Dupas, J., Pillant, H., Picon, L., Veyrac, M., Flamant, M., Savoye, G., Jian, R., DeVos, M., Porcher, R., Paintaud, G., Piver, E., Colombel, J., & Lemann, M.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 142
- Issue
- 1
- Pages
- 63-70.e5
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2031860350
- Cited by
- 597
- References
- 35
- FWCI
- 30.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.